CANQ.F Stock Overview
Develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
CanaQuest Medical Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.03 |
52 Week High | US$0.34 |
52 Week Low | US$0.021 |
Beta | 0 |
11 Month Change | -25.87% |
3 Month Change | -38.78% |
1 Year Change | -90.91% |
33 Year Change | -90.00% |
5 Year Change | -92.86% |
Change since IPO | -98.13% |
Recent News & Updates
Recent updates
Shareholder Returns
CANQ.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 2.6% | 0.5% |
1Y | -90.9% | 13.1% | 30.7% |
Return vs Industry: CANQ.F underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: CANQ.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
CANQ.F volatility | |
---|---|
CANQ.F Average Weekly Movement | 44.0% |
Pharmaceuticals Industry Average Movement | 9.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CANQ.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CANQ.F's weekly volatility has decreased from 67% to 44% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | n/a | Paul Ramsay | canaquest.com |
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
CanaQuest Medical Corp. Fundamentals Summary
CANQ.F fundamental statistics | |
---|---|
Market cap | US$642.34k |
Earnings (TTM) | -US$785.64k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs CANQ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CANQ.F income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$1.10m |
Earnings | -CA$1.10m |
Last Reported Earnings
Mar 31, 2018
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CANQ.F perform over the long term?
See historical performance and comparison